Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salvage brachytherapy for locally recurrent prostate cancer after definitive radiotherapy - a multicentric French cohort by the SFRO brachytherapy group.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Transition from pulsed dose rate to high dose rate brachytherapy: Experience of a single centre.

Brachytherapy·2025
Same author

Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factors.

Clinical and translational radiation oncology·2024
Same author

[Informed consent in radiotherapy care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

[Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same journal

Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles

Related Experiment Video

Updated: Oct 8, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K

Rectal cancer radiotherapy.

V Vendrely1, E Rivin Del Campo2, A Modesto3

  • 1Service d'oncologie radiothérapie, Hôpital Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33600 Pessac, France; Inserm U1035, université de Bordeaux, 33000 Bordeaux, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|December 26, 2021
PubMed
Summary
This summary is machine-generated.

Updated French guidelines for rectal cancer radiotherapy emphasize neoadjuvant chemotherapy to improve survival and reduce surgery necessity. This approach enhances outcomes and explores organ preservation for better patient quality of life.

Keywords:
Cancer du rectumChemotherapyChimiothérapieRadiotherapyRadiothérapieRecorad 2.0Rectal cancerTarget volumesVolumes cibles

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.9K

Related Experiment Videos

Last Updated: Oct 8, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.9K

Area of Science:

  • Oncological radiotherapy
  • Rectal cancer treatment
  • Surgical oncology

Background:

  • Standard treatment for locally advanced rectal cancer involves chemoradiotherapy, surgery (total mesorectal resection), and adjuvant chemotherapy.
  • This strategy reduces local recurrence rates but leads to significant functional sequelae (20-30% morbidity).
  • Neoadjuvant chemotherapy shows promise in improving recurrence-free and metastasis-free survival.

Purpose of the Study:

  • To present updated French society recommendations for rectal cancer radiotherapy.
  • To evaluate the role of neoadjuvant chemotherapy and its impact on treatment strategies.
  • To explore personalized therapeutic approaches and de-escalation strategies for rectal cancer.

Main Methods:

  • Review of recent clinical trials and treatment outcomes.
  • Integration of improved imaging (MRI for circumferential margin assessment).
  • Consideration of intensity-modulated radiotherapy and refined surgical techniques.

Main Results:

  • Neoadjuvant chemotherapy combined with chemoradiotherapy achieves complete pathological response in up to 30% of tumors.
  • High response rates challenge the necessity of systematic radical surgery in select patients.
  • Advances in imaging and radiotherapy enable personalized treatment and morbidity reduction.

Conclusions:

  • Personalized therapeutic strategies, including neoadjuvant chemotherapy and improved surgical/radiotherapy techniques, are crucial for rectal cancer management.
  • De-escalation strategies, such as rectal preservation or radiotherapy omission in good responders, are under investigation.
  • Ongoing trials aim to further refine treatment to minimize morbidity while maintaining efficacy.